BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56.
Source: insidermonkey.com
📰 Waterlase Trial Program News
Waterlase Trial Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Waterlase Trial Program. Real-time updates on events, politics, business and more.
BIOLASE, Inc. (NASDAQ:BIOL) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the BIOLASE Second Quarter 2023 Financial Results Conference Call. Please note this call is being recorded.
Source: insidermonkey.com
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30,...
United States Michael Polyviou Todd Kehrli John Beaver Waterlase Trial Program Source Biolase Inc Biolase Inc
Source: prnewswire.com